NCT05337774View on ClinicalTrials.gov

Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury

PHASE1TerminatedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 7, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2022

Conditions
Mild Traumatic Brain Injury
Interventions
DRUG

[18F]PI-2620

The participant will be injected with 5 mCi (185 MBq) \[18F\]PI-2620 via a short line which will be placed in an intravenous line in an antecubital vein. Subjects will be placed in the scanner after injection and dynamic scans will be acquired for 0 to 60 minutes post injection.

Trial Locations (1)

20889

Walter Reed National Military Medical Center (WRNMMC), Bethesda

Sponsors
All Listed Sponsors
collaborator

Walter Reed National Military Medical Center

FED

lead

Life Molecular Imaging SA

INDUSTRY